Statin treatment and prevalent CVD influence the association between PCSK9 and incident CVD in patients with moderately decreased kidney function: Results from the GCKD study. (August 2022)

Record Type:
Journal Article
Title:
Statin treatment and prevalent CVD influence the association between PCSK9 and incident CVD in patients with moderately decreased kidney function: Results from the GCKD study. (August 2022)
Main Title:
Statin treatment and prevalent CVD influence the association between PCSK9 and incident CVD in patients with moderately decreased kidney function: Results from the GCKD study
Authors:
Kheirkhah, A.
Lamina, C.
Kollerits, B.
Schachtl-Riess, J.F.
Schultheiss, U.T.
Forer, L.
Sekula, P.
Kotsis, F.
Köttgen, A.
Eckardt, K.U.
Kronenberg, F.
Abstract:
Is Part Of:
Atherosclerosis. Volume 355(2022)
Journal:
Atherosclerosis
Issue:
Volume 355(2022)
Issue Display:
Volume 355, Issue 2022 (2022)
Year:
2022
Volume:
355
Issue:
2022
Issue Sort Value:
2022-0355-2022-0000
Page Start:
2
Page End:
Publication Date:
2022-08
Subjects:
Arteriosclerosis -- Periodicals
Electronic journals
616.136
Journal URLs:
http://www.sciencedirect.com/science/journal/00219150 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/00219150 ↗
http://www.elsevier.com/journals ↗
DOI:
10.1016/j.atherosclerosis.2022.06.008 ↗
Languages:
English
ISSNs:
0021-9150
Deposit Type:
Legaldeposit
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:
British Library DSC - 1765.874000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:
23286.xml